Booklets & Guides
Treatment Options
Filter by:
Or browse by
popular tag:
Booklets & Guides
Neuroendocrine tumours: A guide for patients and carers
Treatment Options
New Medicare item for PRRT (Lu-DOTA) added from 1 November 2025
Clinical Trials
ONJCRI Immunotherapy Trial: Nivolumab & Ipilimumab for Rare and Advanced Cancers
This protocol provides an important opportunity to establish whether the combination of nivolumab & ipilimumab has efficacy in these cancers.
Fact Sheets
Palliative Care & End of Life Care Resource List
Fact Sheets
Para & Phaeo Factsheet
Clinical Trials
PARP Inhibitor With 177Lu-DOTA-Octreotate PRRT in Patients With Neuroendocrine Tumours (PARLuNET)
PARLuNET is a phase 1 dose-escalation study designed to evaluate the safety and tolerability of talazoparib (PARP Inhibitor) in...
Educational Videos, Explainer Videos
Peptide receptor radionuclide therapy (PRRT)
Clinical Trials
Phase 3 Trial of CAM2029 vs Standard Treatments in GEP-NET Patients
The purpose of this study is to compare the effectiveness and safety of CAM2029 to octreotide LAR or lanreotide ATG in patients with advanced, well-differentiated GEP-NET.
Fact Sheets
PRRT
Treatment Options
PRRT Treatment
Fact Sheets
Questions to Ask
Educational Videos
Questions to ask your Doctor
Fact Sheets
Radiation Therapy
Treatment Options
Radiation Therapy Treatment
Fact Sheets
